| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP binding cassette subfamily C member 8 | 0.474 | 0.846 | 8.0E-24 |
|
group | 0.100 | None | 0 | 2 | |||||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
actin alpha cardiac muscle 1 | 0.610 | 0.538 | 0.74 |
|
group | 0.190 | None | 1.000 | 0 | 0 | 2008 | 2019 | ||||||||
|
actin like 6A | 0.678 | 0.346 | 1.00 |
|
group | 0.100 | None | 0 | 1 | |||||||||||
|
angiogenic factor with G-patch and FHA domains 1 | 0.650 | 0.462 | 2.7E-05 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
APC membrane recruitment protein 1 | 0.570 | 0.654 | 0.85 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
ankyrin 1 | 0.540 | 0.885 | 1.00 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
Rho GTPase activating protein 31 | 0.581 | 0.615 | 1.00 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
group | 0.100 | None | 0 | 1 | |||||||||||
|
AT-rich interaction domain 1B | 0.503 | 0.846 | 1.00 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
ARVCF delta catenin family member | 0.540 | 0.769 | 5.0E-11 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
ASXL transcriptional regulator 2 | 0.617 | 0.692 | 1.00 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | 0.576 | 0.731 | 3.0E-19 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
ATPase H+ transporting V1 subunit A | 0.579 | 0.615 | 0.87 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
ATPase H+ transporting V1 subunit E1 | 0.610 | 0.769 | 0.53 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
activator of transcription and developmental regulator AUTS2 | 0.569 | 0.846 | 1.00 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
beta-1,3-galactosyltransferase 6 | 0.631 | 0.615 | 2.3E-02 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
beta 3-glucosyltransferase | 0.554 | 0.731 | 7.1E-17 |
|
group | 0.110 | None | 1.000 | 0 | 0 | 2011 | 2011 | ||||||||
|
bromodomain adjacent to zinc finger domain 1B | 0.530 | 0.731 | 1.00 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
BCL6 corepressor | 0.471 | 0.808 | 1.00 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
bone morphogenetic protein 2 | 0.432 | 0.846 | 0.99 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
bone morphogenetic protein receptor type 1A | 0.522 | 0.731 | 0.90 |
|
group | 0.110 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.100 | None | 0 | 0 |